Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Conditions
Mesothelioma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Duke Cancer Institute, Durham, North Carolina, United States
Baylor St Lukes, Houston, Texas, United States
Contact: Principal Investigator (Robert Ripley, MD)
Study leads
Robert Ripley, MD
Principal Investigator
Baylor College of Medicine